TITANFAC Industries506854Quarterly results

Board approves unaudited Q2 and H1 FY27 results; QIP and preferential allotment details, plant capex update

Board met 2 Nov 2026: unaudited Q2/H1 FY27 results approved; statutory auditor's Limited Review Report enclosed.

By ScoutQuest · Mon 2 Nov 2026, 5:42 PM IST · 4 min read

Q2 Revenue from Operations

Rs 23,048.07 Lakhs

H1 Revenue from Operations

Rs 41,785.80 Lakhs

Fluorinated Products Plant Capex

Rs.49,500 Lakhs, 20,000 MTPA at existing site, under implementation

What the board approved

TANFAC Industries' board met on Monday, November 02, 2026, from 12:30 p.m. to 05:20 p.m. IST and approved the unaudited financial results for the second quarter and half year ended September 30, 2026. The results were reviewed by the Audit Committee, approved by the board and subjected to a limited review by the statutory auditors, whose Limited Review Report is enclosed with the results. Figures below are as printed, in Rs in Lakhs.

Quarter ended September 30, 2026 (with the year-ago quarter)

• Revenue from operations: 23,048.07, against 16,699.00
• Total Revenue: 23,429.08, against 16,930.64
• Profit for the period: 1,902.79, against 1,717.94
• Finance Cost: 189.31, against 76.07
• Basic EPS: Rs 8.93, against Rs 8.61

Half year ended September 30, 2026 (with the year-ago half)

• Revenue from operations: 41,785.80, against 34,469.30
• Total Revenue: 42,331.91, against 34,625.59
• Profit for the period: 3,587.75, against 3,653.13
• Basic EPS: Rs 17.35, against Rs 18.31

Top line rose in both periods, while half-year profit came in a shade below the year-ago half. Note 9 states that EPS for all comparative periods shown has been restated for the share split described below.

Capital and fund raising

• Qualified Institutional Placement: a board resolution dated 9 January 2026 and a shareholders' resolution passed at the EGM held on February 23, 2026 approved raising funds up to Rs 50,000 Lakhs; 12,58,318 equity shares of Rs 5 each were allotted at Rs 1055.83 each (including a premium of Rs 1,050.83 per share).
• Preferential allotment: 4,24,647 equity shares of Rs 5 each at Rs 2,341 each (including a premium of Rs 2,336 per share); listing approval was received on October 8, 2026 and trading approval on October 9, 2026.
• Paid-up equity share capital is shown at Rs 1,081.68 Lakhs comprising 2,16,33,506 equity shares of Rs 5 each, against Rs 997.50 Lakhs at March 31, 2026.
• Share split: one equity share of face value Rs 10 was sub-divided into two equity shares of face value Rs 5, with effect from March 9, 2026.
• Use of proceeds, as on September 30, 2026: Rs 6,795.91 Lakhs of the QIP proceeds was in an Escrow Account, Fixed Deposits and Debt oriented Mutual Funds, and Rs 7,555.15 Lakhs of the preferential issue proceeds was in Fixed Deposits, in each case pending utilisation for the stated objects.

New plant

• The board had approved, at its meeting held on 9 January 2026, setting up a 20,000 MTPA new downstream Fluorinated product plant at the existing manufacturing location, at an estimated cost of Rs.49,500 Lakhs, estimated to be commissioned in twelve months. The project is currently under implementation.

Other items in the notes

• A final dividend of Rs. 4.50 per equity share of face value Rs. 10 for the financial year 2025-26 was recommended by the board on 6th May 2026, approved by shareholders at the Annual General Meeting held on 23rd September 2026 and paid.
• The company operates in a single segment, Chemicals in India.

Balance sheet as at September 30, 2026 (against March 31, 2026)

• Total assets: 1,00,601.34, against 52,773.61
• Total equity (shareholders' funds): 73,677.29, against 37,316.57
• Non-current borrowings: 6,611.11, against nil; current borrowings: 6,951.57, against 9,281.49
• Cash & cash equivalents: 9,811.60, against 2,107.39
• Inventories: 14,726.52, against 9,284.22

Cash flow for the half year ended September 30, 2026

• Net cash generated from / (used in) operating activities: (3,092.52)
• Purchase of Property, Plant and Equipment including Capital Work-in-Progress, capital advances and capital goods in transit: (22,163.26)
• Net cash from financing activities: 37,657.56, which includes issue of shares (including securities premium) of 33,732.76
• Net increase in cash and cash equivalents: 7,704.21

How to read this

The announcement combines three things in one update: the quarterly numbers, where revenue from operations is higher year on year in both the quarter and the half year while half-year profit is marginally lower; the completion of two rounds of equity issuance that have enlarged the share capital and brought in cash that is still to be spent on the stated objects; and the ongoing 20,000 MTPA fluorinated products project with an estimated cost of Rs.49,500 Lakhs. On the operating cash side, the half year shows cash used in operating activities, with the bulk of the money movement coming from share issuance and spending on property, plant and equipment. Readers may want to track the deployment of the escrow and fixed deposit balances into the stated objects and the commissioning timeline of the new plant.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev